Scientific Sessions

Platelet-rich plasma (PRP) and cellular therapies have emerged as promising minimally invasive treatments in orthopedic and musculoskeletal care. PRP involves concentrating a patient’s own platelets and growth factors, which are then injected into injured tissues to stimulate healing, reduce inflammation, and promote tissue regeneration. It is widely used for conditions such as tendon injuries, ligament tears, osteoarthritis, and chronic joint pain, offering an alternative to surgery with minimal downtime.

Cellular therapies, including stem cell injections derived from bone marrow or adipose tissue, complement PRP by facilitating the repair and regeneration of cartilage, bone, and soft tissues. Advances in delivery techniques, imaging guidance, and combination therapies have enhanced precision and treatment outcomes, ensuring that cells reach the targeted area effectively. Together, PRP and cellular therapies represent a shift toward biologically driven, personalized care in orthopedics, reducing recovery time, improving functional outcomes, and providing patients with innovative solutions for musculoskeletal injuries and degenerative conditions.